PATENT CLAIM ANALYSIS

Application Number: 16276711
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-07
Patent Classification: ["424", "187100"]

Abstract:
The present relation relates to a transgenic Vero cell line expressing CD4 and CCR5. The present invention encompasses the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.

Claim (Index 6):
The cell line of  claim 1 , wherein the cell line is transformed with the construct of  FIG. 35 .

Metadata:
- Claim Count in Document: 8.0
- Percentile: 99.0
- Lexical Diversity: 1.32143
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15481108', '15280710', '13792106', '14972272', '15663867']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8325957613745449
- 35 USC 102 Novelty (BERT): 0.5888353904608422
- Combined Prediction Score: 0.8082197242831747
- Mean Citation Score: 538.857942
- Max Citation Score: 791.6465
- Similarity Product: 415.57381383043526

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test